National Policy for Rare Diseases 2021 addresses diagnosis and treatment, categorizing diseases and advocating for affordable ...
It was submitted that why can't the Indian government negotiate with Roche to make the medicine for the rare disorder ...
The imposition of a 26% reciprocal tariff by the United States on Indian medical device exports has raised serious concerns ...
Can the medicine for treatment of rare disorder spinal muscular atrophy (SMA) be made available at lower price in India, if ...
The Supreme Court on Friday asked the Centre and the manufacturer of the drug Risdiplam, which is used for the treatment of ...
The Supreme Court of India seeks responses from the Centre and Roche on making the spinal muscular atrophy treatment drug ...
The Supreme Court has sought responses from the Centre and pharmaceutical giant Roche on why their SMA treatment drug, ...
FDA-approved treatments for spinal muscular atrophy differ in their mechanisms of action, safety profiles, and administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback